Paper Details
- Home
- Paper Details
[Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases].
Author: JiZhi-gang, LiHan-zhong, PanDong-liang, ZengZheng-pei
Original Abstract of the Article :
OBJECTIVE: To compare the effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma. METHODS: Phenoxybenzamine 30-240 mg/d was given orally to 38 patients of pheochromcytoma for 3 weeks. After the blood pressure was restored to the primary level before ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/16029653
データ提供:米国国立医学図書館(NLM)
Pheochromocytoma Treatment: A Balancing Act of Blood Pressure and Side Effects
The management of [pheochromocytoma] involves a delicate balancing act of controlling [blood pressure] while minimizing [side effects]. This study compares the efficacy of [doxazosin mosylate] and [phenoxybenzamine] in achieving [preoperative volume expansion] in patients with [pheochromocytoma]. The researchers conducted a [comparative study] to evaluate the [effectiveness] and [side effects] of these two medications.
Doxazosin Mosylate: A More Gentle Approach to Pheochromocytoma Management
The study's findings suggest that [doxazosin mosylate] may be a more suitable option for patients with [pheochromocytoma] who have [mild or moderate levels of blood pressure]. While [phenoxybenzamine] was more effective in achieving [complete volume expansion], it was also associated with a higher rate of [side effects]. Doxazosin mosylate, on the other hand, showed a lower [complete volume expansion rate] but had a significantly lower [side effect rate]. This suggests that doxazosin mosylate may be a more tolerable option for patients with [pheochromocytoma] who are seeking to minimize [side effects].
Navigating the Shifting Sands of Pheochromocytoma: Choosing the Right Path
This research, like a guide through a shifting desert landscape, provides valuable insights into the management of pheochromocytoma. The study highlights the importance of choosing the right medication based on the patient's individual needs and blood pressure levels. By carefully weighing the benefits and risks of different treatment options, clinicians can navigate the complexities of pheochromocytoma and provide the best possible care for their patients.
Dr.Camel's Conclusion
Pheochromocytoma, like a mirage in the desert, can be a tricky condition to manage. This study provides valuable guidance for choosing the right medication, considering factors such as blood pressure levels and potential side effects. By understanding the nuances of these medications, clinicians can navigate the shifting sands of pheochromocytoma and provide the best possible care for their patients.
Date :
- Date Completed 2006-02-10
- Date Revised 2013-11-21
Related Literature
Chinese
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.